JSPRJasper Therapeutics, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 17584
Ticker: JSPR
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2021-09-27
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: JSPR

Detail

Enriched 2026-08-14 20:47

Market cap: $27,414,910.81
Shares outstanding (class): 28,009,802
Shares outstanding (weighted): 33,274,561
SIC: 2836 BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees: 22
Location: REDWOOD CITY, CA
Homepage: https://www.jaspertherapeutics.com
Description: Jasper Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU) and asthma. The company's lead product candidate, briquilimab, is a monoclonal antibody designed to block stem cell factor (SCF) from binding to and signaling through the CD117 (KIT) receptor on mast and stem cells. The company has a single operating and reportable segment, which is the research and development of therapeutic products in the fields of chronic urticaria and asthma.

Market cap and share counts drift.

Funds holding this security

10 funds · 10 positions · $1.10M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$730.2K	0.00%	833,391 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$273.4K	0.00%	312,032 NS	FIGI
iShares Micro-Cap ETF iShares Trust	IWC	$59.8K	0.00%	68,218 NS	FIGI
VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS	—	$23.8K	0.00%	27,174 NS	FIGI
1290 VT Micro Cap Portfolio EQ Advisors Trust	—	$4.1K	0.00%	4,665 NS	FIGI
Small Cap Core Fund Northern Funds	—	$3.2K	0.00%	3,638 NS	FIGI
JNL/DFA U.S. Small Cap Fund JNL Series Trust	—	$2.2K	0.00%	2,540 NS	FIGI
Total Stock Market Index Trust John Hancock Variable Insurance Trust	—	$684.31	0.00%	781 NS	FIGI
AST Small-Cap Equity Portfolio Advanced Series Trust	—	$683.44	0.00%	780 NS	FIGI
Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds	—	-$1.2K	-0.00%	-1,400 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERJSPR
FIGI_COMPOSITEBBG00QPZNP97
FIGI_SHARE_CLASSBBG00QPZNPB4
CIK0001788028
ISINUS4718712023
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Biotechnology
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Jasper Therapeutics is a clinical-stage biotechnology company developing therapies for inflammatory diseases, fitting the BIOTECHNOLOGY industry under HEALTHCARE.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.